Natural Compounds with Antimicrobial Activities in Oral Candida Infections during Head and Neck Radiotherapy
-
Published:2023-11-14
Issue:
Volume:
Page:1-20
-
ISSN:0009-3157
-
Container-title:Chemotherapy
-
language:en
-
Short-container-title:Chemotherapy
Author:
Imperia Elena,Bonincontro Graziana,Altomare Annamaria,Simonetti Giovanna,Gherardi Giovanni,Brasili Elisa,Badiali Camilla,Bove Manuela,Pasqua Gabriella,De Gara Laura,Cicala Michele,Guarino Michele Pier Luca
Abstract
<b><i>Background:</i></b> Oral colonization and infections are frequently observed in patients during and soon after radiation therapy. Infective <i>mucositis</i> is a common side effect associated with cancer therapy, characterized by an inflammation of the oral mucous membranes with histological mucosal and submucosal changes. Ulcerative mucositis is responsible for significant pain, impairing the patient’s nutritional intake and leading to local or systemic infections promoting mycosis due to several species of the genus C<i>andida</i>. According to international guidelines, treatment of candidiasis depends on the infection site and patient’s condition. <b><i>Summary:</i></b> Recently, several studies have shown the protective role of natural compounds counteracting the activity of <i>Candida</i> biofilms. The aim of this review was to discuss the antimicrobial activities of natural compounds in fungal infections, especially <i>Candida</i> spp., during and soon after radiotherapy. Indeed new molecules are being discovered and assessed for their capacity to control Candida spp. growth and, probably in the future, will be used to treat oral candidiasis, overall, during radiotherapy. This review reports several preliminary data about preclinical and clinical evidence of their efficacy in the prevention and/or treatment of <i>mucositis</i> due to radiotherapy with a brief description of the natural compounds with anti-Candida activities. <b><i>Key Messages:</i></b> The increase in the resistance to the available antifungal drugs related to Candida spp. infections increased as well as drug interactions, urging the development of innovative and more effective agents with antifungal action. Recent preclinical and clinical studies are identifying natural substances with anti-inflammatory and antifungal activity that could be tested in the prevention of candidiasis in patients undergoing radiotherapy. Further studies are needed to confirm these preliminary data.
Subject
Infectious Diseases,Pharmacology (medical),Drug Discovery,Pharmacology,Oncology,General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献